English German Chinese
avocats d'affaires paris

    27/01/2017 - Granrut advises Algaia and its historical investors on its € 6.5 million fundraising

    Stéphane Bénézant, Partner, and Monyvan Chan, Associate, advised Algaia, as well as its historical financial investors – the investment funds FPCI Emertec 4, Amorçage Technologique Investissement and G1J Ile-de-France – on a € 6.5 million fundraising.

    Algaia, a French company focused on marine ingredients and more specifically seaweed extracts, has completed a € 6.5 million fundraising with its historical investors – the investment funds FPCI Emertec 4 and Amorçage Technologique Investissement – and a new strategic investor, Maabarot Products Ltd., a leading provider of health and nutrition products, listed on Tel Aviv stock exchange (TASE).

    This fundraising will allow Algaia to accelerate its development in the field of seaweed and other natural extracts, by completing the recent acquisition of Cargill’s alginate business and manufacturing plant in Lannilis (France), further to the acquisition of Alganact (a French start-up company specialized in seaweed biomass valorisation) in June 2016 and the opening of a greenfield R&D centre in Saint-Lô (France) in September 2016.

    Algaia and its historical investors - the investment funds FPCI Emertec 4 (managed by Demeter-Emertec), Amorçage Technologique Investissement (managed by CEA Investissement) and G1J Ile-de-France (managed by Cap Décisif Management) – were advised by Stéphane Bénézant (Partner) and Monyvan Chan (Associate) of the Granrut M&A team.

    Maabarot Products Ltd was advised by Bersay & Associés (Stéphanie Molkhou, Of Counsel, and Alexandra Basha, Associate) and Ady Kaplan & Co (Dan Kaplan, Partner).

    Source : Granrut

        

Stéphane Bénézant